Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

NCT03415139 · clinicaltrials.gov ↗

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Cancer

Interventions

DRUG: Oral Glucose Tolerance Test (OGTT)
DRUG: 2 OGTTs with and without GLP-1 analogue
DRUG: Hyperglycemic clamp procedure

Sponsor

Vanderbilt-Ingram Cancer Center